|
Non-Federal Funding-Grants
The Hope Foundation SWOG's mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. Any SWOG investigator eligible for NIH funding is encouraged to submit to this program.
Amount: $50,000 for 1-2 years
Deadline: July 1, 2016
The Lung Cancer Research Foundation The Lung Cancer Research Foundation's grant program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer. The Foundation encourages applications for projects investigating a wide variety of research topics.
Amount: Up to $150,000 for 2 years Deadline: July 1, 2016
Damon Runyan Cancer Research Foundation This award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. It is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding.
Amount: Up to $300,000 for 2 years Deadline: July 1, 2016
Susan G. Komen CCR Grants provide unique opportunities for scientists who have held faculty positions for no more than five years at the time of Application to achieve research independence. CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. There are two research focus areas: Basic/Transitional and Clinical.
Amount: Up to $450,000 for 2-3 years Deadline: LOI July 14, 2016
HESI THRIVE
THRIVE Research Grant Program
THRIVE offers funding for basic science, clinical, and transitional research that enhances our ability to predict when and how adverse effects may occur in patients who have received cancer treatment and supports the development of approaches to avoid or lessen these effects. THRIVE gives preference to those innovative research projects that engage both non-clinical AND clinical scientists in the research project design and/or implementation.
Amount: Up to $50,000 for 2 years
Deadline: LOI July 15, 2016
Free To Breathe Free to Breathe has a new funding opportunity focused on research to investigate strategies and interventions to increase clinical trial accrual to therapeutic lung cancer clinical trials. Applicants may not have knowingly received any research funding from the tobacco industry, its parent companies, or subsidiaries, within the last 5 years.
Amount: Up to $100,000 for 2 years Deadline: July 17, 2016
The mission of the Breast Cancer Alliance (BCA) is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure.
Amount: $125,00 for 2 years
Deadline: July 22, 2016
American Heart Association (AHA) The objective of the IRG is to support highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research. Candidates with a faculty (or faculty equivalent) appointment are eligible to apply. An applicant may onlly submit one association-wide IRG application and one other association-wide application per deadline. Amount: $150,000 for 2 years Deadline: July 26, 2016
All applications are due in the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review and approval prior to submission to the sponsor.
| 
